Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
Funding will be used to commercialize its unique cardiology technology and commence the first-in-human clinical study of the Ceryx Medical innovative cardiac rhythm management device, Cysoni, later this year.
SoftBank Robotics Group notes upon the completion of the transaction, SBRG will own approximately 5% stake in Avalon’s disinfection business.
Blue Spark Technologies notes funding will go towards scaling the company’s sales and marketing functions and the continued advancement of Blue Spark’s wearable remote patient monitoring solutions.
Copyright © 2025 Medical Device News Magazine, a division of PTM Healthcare Marketing, Inc. All Rights Reserved
Hours:
M – F 8 am – 5 pm ET
Florida / New York
Phone: 561.316.3330